Short Summary
TCL Electronics has petitioned the PTAB to institute an IPR against Maxell’s U.S. Patent 10,650,780 covering a display apparatus that uses USB and wireless LAN. The petition relies on the Lawther prior‑art reference to argue obviousness of claims 1‑11, 13, and 15‑20 under 35 U.S.C. § 103.
Detailed Summary
In Petition IPR2025‑00134, TCL Industries Holdings (f/k/a TCL Multimedia Technology Holdings) seeks institution of inter‑partes review of Maxell’s U.S. Patent 10,650,780, which claims a display apparatus that receives images from a portable device via both USB and wireless LAN and presents them as a slide show. The petitioner asserts that the Lawther patent‑application publication (2008/0165081) anticipates every limitation of the challenged claims, rendering them obvious under pre‑AIA 35 U.S.C. § 103. The petition includes a detailed claim‑by‑claim analysis, expert declaration by Dr. Andrew Wolfe, and a Sotera stipulation to avoid discretionary denial. No settlement or prior PTAB action is noted; the proceeding remains at the petition stage.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in TCL Industries Holdings Co., Ltd. vs Maxell, Ltd. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
AZURITY PHARMACEUTICALS, INC.vsHelsinn Healthcare S.A.
AZURITY PHARMACEUTICALS successfully petitioned to institute IPR proceedings against Helsinn Healthcare S.A.'s anti-emetic patent (8623826). The Board found a reasonable likelihood of prevailing on independent claim 19, allowing the challenge based on obviousness over prior art like MASCC and Hoffmann.
Taiwan Semiconductor Manufacturing Company Ltd.vsAdvanced Integrated Circuit Process LLC
Court decision.
Zhuhai CosMX Battery Co., Ltd.vsNingde Amperex Technology Ltd.
The PTAB granted institution for the petitioner's IPR challenge against U.S. Patent 12,015,118 B2, covering lithium-ion battery electrode structures. The Board found reasonable likelihood of prevailing on both anticipation (Ishigaki) and obviousness grounds over multiple prior art references.
Micron Technology, Inc. et al.vsYangtze Memory Technologies Company, Ltd.
Micron Technology, Inc. lost its request for rehearing after the PTAB denied institution of IPR against Yangtze Memory Technologies Company regarding NAND Flash memory patents.
Aquestive Therapeutics, Inc.vsIono Pharma, LLC
Aquestive Therapeutics has filed an IPR petition seeking to invalidate claims 1‑3 of Iono Pharma’s ‘437 patent covering sublingual/ buccal epinephrine prodrugs. The challenger relies on obviousness over multiple prior‑art references, including Truelove patents, an academic paper, and the Almoazen paper.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.